Articles tagged with Vaccination
Researchers at Northwestern University developed an AI-powered tool to speed up the search for COVID-19 treatments and vaccines. The model predicts which studies are most likely to be replicable, allowing researchers to prioritize resources on promising research.
A $10 million grant enables the Murdoch Children's Research Institute's clinical trial of the BCG vaccine against COVID-19 to expand to 10,000 healthcare workers across Australia and Europe. The BRACE trial aims to test whether the BCG vaccine can protect those exposed to SARS-CoV-2 from developing severe symptoms.
Researchers mapped the glycan-processing states of the SARS-CoV-2 spike protein using high-resolution mass spectrometry. The study found that SARS-CoV-2 glycans differ from typical host glycan processing, which may impact vaccine effectiveness.
Experts warn that immunity passports pose significant practical, equitable, and legal issues. Vaccination certificates, on the other hand, may be a crucial tool to incentivize vaccination and end the pandemic. The success of public health practices depends on public trust and addressing inequities.
The CUNY SPH Weekly COVID-19 Survey reveals New Yorkers are cautious about resuming normal activities due to the ongoing pandemic. Many believe a safe and effective vaccine is essential for restoring public confidence.
Researchers have developed a method of lymphocytic vaccination to counter autoimmune diseases, proving clinically effective in treating multiple sclerosis and rheumatoid arthritis. The technology involves creating an immunology cell bank to enhance immunological protection against infection.
The pneumococcal conjugate and rotavirus vaccines significantly reduce acute respiratory infections and diarrhea among small children, resulting in fewer cases of antibiotic treatment. These vaccines have the potential to prevent millions of episodes of antibiotic-treated illness if universally adopted.
A recent study evaluated Medicaid benefits coverage and reimbursement amounts for recommended adult vaccines across all 50 states and the District of Columbia. The findings suggest that state policies vary widely, with some states providing more comprehensive vaccination services than others.
This study reviews possible clinical strategies for defeating coronavirus, including the use of vaccines, broad-spectrum antivirals like remdesivir, and gene therapy. The authors propose these approaches as promising alternatives to develop effective treatments against SARS-CoV-2 and related coronaviruses.
The University of Saskatchewan's VIDO-InterVac has been awarded $23 million to fast-track COVID-19 vaccine development. The funding will support pre-clinical testing and two phases of clinical trials, with the goal of making a safe and effective vaccine available as early as next spring.
Researchers at UC San Diego are developing a COVID-19 vaccine using a plant virus, which can be easily manufactured and distributed globally. The team plans to create slow-release microneedle patches that patients can self-administer, reducing barriers to vaccination in resource-poor areas.
A Cochrane Review confirms the effectiveness of MMR vaccines in preventing infectious diseases such as measles, mumps, and rubella. The review found that one dose of vaccine was 95% effective in preventing measles and 89% effective in preventing rubella, with no association between the vaccines and autism or other conditions.
Scientists at Cincinnati Children's Hospital Medical Center report development of a potential universal vaccine for Ebola viruses. The new vaccine uses glycoproteins from two Ebola virus species and has shown promise in neutralizing all four pathogenic species, generating cross-reactive responses against multiple viruses.
A new study by URMC aims to investigate how the body's immune system responds to COVID-19, including re-infection risks and vaccine effectiveness. The research will follow 100 COVID-19 patients over 90 days, tracking antibody production and immune cell activation.
New Yorkers face difficulties with schooling at home, particularly for parents with lower education levels; vaccination hopes are mixed, with 53% of respondents willing to get vaccinated. The most trusted source of information is Governor Andrew Cuomo, according to the CUNY SPH weekly COVID-19 survey.
Research finds people with vaccine skepticism tend to overestimate the likelihood of rare negative events, including mortality-related causes. This suggests a possible explanation for their concerns: cognitive or affective variables influencing vaccine skepticism.
Researchers develop vaccine candidate using RNA virus to produce S protein, triggering immune responses against coronaviruses like SARS-CoV-2. The approach effectively blocks MERS virus infections in mice, suggesting potential for COVID-19 prevention.
A study conducted in northwestern São Paulo found that nearly a third of the population under 40 lacked immunity against measles, with only 1% over 50 showing similar results. Vaccination remains essential in preventing transmission and controlling outbreaks.
Phony Russian Twitter accounts contributed to the politicization of vaccine discussions among Americans, leading to increased polarization. Researchers found that pro-Trump personas expressed anti-vaccine sentiments, while anti-Trump personas supported vaccines.
Researchers at the Babraham Institute found that applying genital wart treatment can enhance the immune system of older mice and humans. By boosting T follicular helper cells, they were able to rescue age-dependent defects in immune cell types, offering hope for improving vaccination response in older populations.
Researchers at Texas Biomed launched a comprehensive multi-species study to identify the best animal model for COVID-19. The study includes four additional species and aims to pinpoint the most effective model for diagnostics, vaccines, and therapies.
VIDO-InterVac will receive $12 million in federal funding to construct a pilot-scale vaccine manufacturing facility and $11.3 million for continued operational funding, enabling the development of a human vaccine for COVID-19.
A new oral poliovirus vaccine is urgently needed due to ongoing mutant polio outbreaks. The current OPV2 formulation's continued use contributes to transmission and outbreaks, prompting the need for a novel serotype 2 vaccine.
Combining therapeutic HPV vaccine ISA101 with chemotherapy drugs carboplatin and paclitaxel may extend survival in patients with advanced cervical cancer. The vaccine was well-tolerated, reducing suppressive myeloid cells to better stimulate T cell responses.
Research by University of Otago found significant levels of negative information about vaccines available online, including on Google, Facebook, and YouTube. Health professionals can help inform parents by referring them to credible websites containing well-validated information.
Researchers analyzed published scientific data on SARS-CoV-2 and related coronaviruses to identify potential therapeutic agents and vaccines. More than 500 patents have been issued for COVID-19 treatments, including antibodies and nucleic acids.
A Swedish-Finnish study found that HPV vaccination of both boys and girls prevents infections effectively, even if only 80% of girls are vaccinated. Mathematical modelling shows that vaccinating both genders can eliminate the most oncogenic HPV type 16 in a few years after age 30.
A randomized controlled trial found that tailored messages addressing HPV vaccine concerns improved intent to vaccinate, while a bundled approach was less effective. The study suggests that personalized messaging may be essential for increasing HPV vaccination uptake among hesitant parents.
A study of 109,908 non-migrant individuals found that routine childhood vaccination was associated with 0.2-0.3 additional schooling grades among adults, a significant link across socioeconomic and demographic factors. The finding supports the long-term benefits of vaccines beyond health outcomes.
Researchers at UT Austin found a correlation between higher median incomes, urbanization, and lower vaccination rates among white, educated Texans. The study identified pockets of high-risk communities in Texas where outbreaks of vaccine-preventable diseases are more likely to occur.
A large observational study of nearly 387,000 children found no association between rotavirus vaccination and the development of type 1 diabetes. Researchers noted limitations and potential confounding variables that may have affected results.
A University of Saskatchewan research team has been awarded nearly $1 million to develop animal models and test vaccine candidates for the new coronavirus. The project aims to identify suitable animal models to replicate human disease, with a goal of developing a pan-coronavirus vaccine.
Researchers discovered that pre-immunization with common childhood vaccines can boost anti-tumor efficacy when combined with a hybrid viral platform called PeptiCRAd.
A recent study published in Clinical Infectious Diseases found that adults who completed their childhood vaccination series against tetanus and diphtheria are protected for life. The researchers compared data from millions of people across North America and Europe between 2001 and 2016, concluding that booster shots are not necessary.
The Vaccine For Children (VFC) Program has increased vaccination rates and reduced social disparities among Medicaid-insured children. Pediatricians value the program for its ability to provide free vaccinations regardless of payment status, leading to improved overall vaccination rates.
A breakthrough in coronavirus research has led to the creation of a 3D atomic scale map of the part of the virus that attaches to and infects human cells. This mapping is crucial for developing vaccines and antiviral drugs against the 2019 novel coronavirus.
A study found that people exposed to vaccine content on social media were more likely to be misinformed about vaccines than those exposed to it on traditional media. Up to 20% of respondents were at least somewhat misinformed, with common claims including the link between vaccines and autism.
A recent study published in BMJ Case Reports highlights the serious complications of measles, including hepatitis, appendicitis, and viral meningitis. The authors report on three cases of adults treated for measles, highlighting the need for urgent efforts to ensure global coverage with two-dose measles vaccines.
A study found that HPV vaccination rates dropped significantly after the government's suspension of proactive recommendations, leading to potential 5,000 additional deaths. Restoring high-level political support and proactive recommendations could prevent most of this damage.
A new study found that the Zoster Vaccine Live shingles vaccination may prevent some older adults from having a stroke, reducing the risk by about 16% for ischemic stroke and 12% for hemorrhagic stroke. The vaccine's protection was strongest among people ages 66 to 79 years.
Rutgers researchers found young sexual minority men lack knowledge about HPV and its importance. Health care providers often inadequately discuss the virus and vaccine with these patients.
Recent advances in TB diagnostics, treatments and prevention offer hope for reducing and ultimately eliminating the burden of tuberculosis. The National Institute of Allergy and Infectious Diseases has made significant progress in improving TB diagnostics, therapeutic regimens and prevention approaches.
A single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer. The risk of preinvasive cervical disease was lower in adolescents who received one, two, or three doses of the HPV vaccine compared to unvaccinated teens.
A phase 2 randomized trial study found that patients who received the Triplex vaccine had 50% fewer CMV complications and developed immunity against the virus. The vaccine showed promise as a potential therapy for transplant recipients with weakened immune systems.
A novel vaccine called Triplex reduced CMV complications by half and induced immunity in patients undergoing allogeneic hematopoietic stem cell transplant. No vaccine-associated safety concerns were identified in the phase 2 randomized clinical trial.
A new study found that peace of mind plays a significant role in parents' attitude towards vaccines, with reassurance from knowledge of benefits and healthcare providers influencing decisions. The research suggests that decision makers should consider these benefits when making funding decisions.
Researchers have identified a potential vaccine to prevent respiratory infections in humans by understanding how the human metapneumovirus (HMPV) hides from the immune system. A mutated form of HMPV was created, which triggers a stronger innate immune response, effectively preventing infection and promoting an adaptive immune response.
Researchers propose using genomic data and mathematical modelling to design vaccines for the specific geographic location where they will be used. This approach aims to minimize rates of pneumococcal disease, a serious infection that can cause pneumonia, sepsis, and bacterial meningitis.
A new study shows that a single dose of the Army-developed Zika vaccine can induce potent cross-neutralizing antibody responses against both Zika and dengue viruses. Researchers found that these antibodies, called MZ4, protected against both viruses in a mouse model of infection.
Researchers at Helmholtz Zentrum München developed a novel therapeutic approach to cure chronic hepatitis B infection. By knocking down the expression of the virus' proteins, they enabled successful vaccination with TherVacB, a novel therapeutic vaccine. The therapy aims to cure existing chronic diseases by activating immune cells.
A team of international scientists has created a global map of dengue transmission intensity and predicted that releasing infected mosquitoes with Wolbachia could reduce cases by up to 90%. The study also suggests that the Sanofi Pasteur dengue vaccine could reduce cases by up to 30%.
The study found good protection against meningococcal disease in vaccinated individuals, but no overall reduction in bacterial carriage. The findings highlight the importance of individual vaccination and identify high-risk behaviors associated with bacterial transmission.
Researchers Aarthi Narayanan and Remi Veneziano at George Mason University are developing a new vaccine design using DNA origami to deliver viral antigens. The customizability of the DNA structures enhances immunogenic potential while ensuring safety.
A new method to produce cheaper, longer-lasting vaccines has been developed using a protein called polyhedrin. Researchers found that PH(1-110) particles stored as dry powder can still generate antibodies after up to twelve months of storage.
A new analysis of HPV vaccine clinical trials raises doubts about their effectiveness, citing methodological problems and limited trial populations. The study found that the trials were not designed to detect cervical cancer, which takes decades to develop, and that vaccination may only prevent low-grade abnormal cell changes.
A study published in PLOS Neglected Tropical Diseases found that typhoid prevalence is likely higher than estimated due to missed blood cultures, with patients more likely to have cultures if older, feverish or suspected urinary tract infection.
Researchers developed a novel cryogel vaccine that primes the immune system to attack and eliminate acute myeloid leukemia cells in mice. The vaccine successfully protected against disease recurrence when combined with chemotherapy.
The International Vaccine Institute (IVI) has renewed its partnership with Sweden's Swedish International Cooperation Agency (Sida) to accelerate vaccine research and development for global health. The five-year partnership will focus on infectious diseases of global importance, including cholera, typhoid, and dengue.
The Partnership for Research on Ebola Vaccination (PREVAC) has received additional funding to evaluate three Ebola vaccine regimens for long-term safety and durability. The PREVAC-UP project will assess these factors over 5 years after vaccination, as well as the impact of co-infections like malaria and helminths on immune responses.
The AAFP has released updated Feline Retrovirus Testing and Management Guidelines, providing current information on pathogenesis, diagnosis, prevention, and treatment. The guidelines aim to optimize care for feline patients infected with FeLV and FIV, and offer practical guidance for veterinarians and cat caregivers.